ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$3.97
+0.09 (+2.32%)
Open$3.89
Previous Close$3.88
Day High$4.07
Day Low$3.83
52W High$5.01
52W Low$1.98
Volume—
Avg Volume154.4K
Market Cap158.79M
P/E Ratio1.45
EPS$2.59
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+140.6% upside
Current
$3.97
$3.97
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.36M | 2.02M | 32.28M |
| Net Income | 62.11M | 58.29M | 5.51M |
| Profit Margin | 412.3% | 3,042.4% | 17.1% |
| EBITDA | -14,513,533 | -14,282,160 | 8.62M |
| Free Cash Flow | — | — | 3.23M |
| Rev Growth | — | -9.5% | +15.3% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |